Status:
NOT_YET_RECRUITING
Amino Acids for Cardiac Surgery Associated AKI
Lead Sponsor:
Stanford University
Conditions:
Acute Kidney Injury
Eligibility:
All Genders
1-18 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to assess the feasibility of amino acid infusions in pediatric cardiac surgery patients.
Eligibility Criteria
Inclusion
- Undergoing cardiac surgery and expected to be high risk
Exclusion
- preoperative extracorporeal organ support
- CKD history (GFR\<60ml/min/1.73m2 \[≤1year\] and GFR\<90ml/min/1.73m2 \[\>1 year\])
- serum creatinine defined preoperative AKI.
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07001098
Start Date
September 1 2025
End Date
November 1 2026
Last Update
June 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lucile Packard Children's Hospital
Palo Alto, California, United States, 94305